Additionally, patients should feel confident in their injection technique and weekly administration routine
#ViaBenefits #GLP1 #Medicare To view or add a comment, sign in The Medicare GLP-1 Bridge Program introduces new access to high-cost obesity treatments and new decisions for employers
Advanced liver disease/cirrhosis requires specialist management
Because none of these peptides are FDA-approved for the uses we describe, the supervision around them is a real part of the treatment: baseline labs, a written protocol, follow-up testing, and an honest conversation about where the evidence sits for each molecule
The most common gastrointestinal side effects include nausea (15-44%), diarrhea (8-30%), vomiting (5-24%), and abdominal pain
Neurological symptoms deserve particular attention